We are currently conducting an in-depth investigation into the potential pathogenic link between Mst1/2 and Parkinson’s disease, including examination of the expression and genetic alterations of Mst1/2 in Parkinson’s disease patients and relevant models. The gene discussed is MST1; the disease is Parkinson disease.